<code id='A3678E3254'></code><style id='A3678E3254'></style>
    • <acronym id='A3678E3254'></acronym>
      <center id='A3678E3254'><center id='A3678E3254'><tfoot id='A3678E3254'></tfoot></center><abbr id='A3678E3254'><dir id='A3678E3254'><tfoot id='A3678E3254'></tfoot><noframes id='A3678E3254'>

    • <optgroup id='A3678E3254'><strike id='A3678E3254'><sup id='A3678E3254'></sup></strike><code id='A3678E3254'></code></optgroup>
        1. <b id='A3678E3254'><label id='A3678E3254'><select id='A3678E3254'><dt id='A3678E3254'><span id='A3678E3254'></span></dt></select></label></b><u id='A3678E3254'></u>
          <i id='A3678E3254'><strike id='A3678E3254'><tt id='A3678E3254'><pre id='A3678E3254'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:8
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Readout Newsletter: Amgen, Regeneron, BGI Group and more
          Readout Newsletter: Amgen, Regeneron, BGI Group and more

          KristofferTripplaar/SipaviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toget

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Gritstone Bio's cancer vaccine test, and more on Novartis' deal

          MollyFerguson/STATThisweek,IaddresspushbackIreceivedonmyNovartis-MorphoSyscolumn.Butfirst,apreviewof